Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease

Inflammatory Bowel Diseases

Volumn 18, Issue 5, 2012, Pages 849-856

  Adler, Jeremy ^a   Punglia, Darashana R ^b   Dillman, Jonathan R ^a   Polydorides, Alexandros D ^a   Dave, Maneesh ^c   Al Hawary, Mahmoud M ^a   Platt, Joel F ^a   McKenna, Barbara J ^a   Zimmermann, Ellen M ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; CT enterography; Fibrosis; Histology; Stricture

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; CROHN DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATORY DISEASE; INTESTINAL FIBROSIS; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMALL INTESTINE DISEASE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; INFANT; INFLAMMATION; INTESTINE, SMALL; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84859792443     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21801     Document Type: Article

References (32)

1. Zimmermann EM, Lund PK. Fibrogenesis in inflammatory bowel disease. In: Kirsner J, ed. Inflammatory Bowel Disease. Philadelphia: W.B. Saunders; 2003.
2. Pucilowska JB, Williams KL, Lund PK. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol. 2000;279:G653-659.
3. Kumagai S, Kawano S, Atsumi T, et al. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. J Rheumatol. 2005;32:863-869. (Pubitemid 40676497)
4. Bollet AJ, Black R, Bunim JJ. Major undesirable side-effects resulting from prednisolone and prednisone. JAMA. 1955;158:459-463.
5. Whitworth JA. Adrenocorticotrophin and steroid-induced hypertension in humans. Kidney Int. 1992;37:S34-37.
6. Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994;96:115-123. (Pubitemid 24070529)
7. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-2284. (Pubitemid 350190758)
8. Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum. 2000; 43:1141-1145. (Pubitemid 30626148)
9. Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum. 2007;50:331-336. (Pubitemid 46393968)
10. Gervais DA, Hahn PF, O'Neill MJ, et al. Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years. Radiology. 2002;222:645-651. (Pubitemid 34215208)
11. Post S, Betzler M, von Ditfurth B, et al. Risks of intestinal anastomoses in Crohn's disease. Ann Surg. 1991;213:37-42.
12. Steffes C, Fromm D. Is preoperative parenteral nutrition necessary for patients with predominantly ileal Crohn's disease? Arch Surg. 1992; 127:1210-1212.
13. Bodily KD, Fletcher JG, Solem CA, et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography - correlation with endoscopic and histologic findings of inflammation. Radiology. 2006;238:505-516. (Pubitemid 43134363)
14. Taylor SA, Punwani S, Rodriguez-Justo M, et al. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination - pilot study. Radiology. 2009;251:369-379.
15. Aro P, Ronkainen J, Talley NJ, et al. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005;54:1377-1383. (Pubitemid 41375191)
16. Joo JS, Agachan F, Wexner SD. Laparoscopic surgery for lower gastrointestinal fistulas. Surg Endosc. 1997;11:116-118. (Pubitemid 127523119)
17. Young S, Smith IS, O'Connor J, et al. Results of surgery for Crohn's disease in the Glasgow region, 1961-70. Br J Surg. 1975;62:528-534.
18. Lazarev M, Ullman T, Schraut WH, et al. Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis. 2010;16:830-835.
19. Soyer P, Boudiaf M, Sirol M, et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology. 2010;254:755-764.
20. Liu YB, Liang CH, Zhang ZL, et al. Crohn disease of small bowel: multidetector row CT with CT enteroclysis, dynamic contrast enhancement, CT angiography, and 3D imaging. Abdom Imaging. 2006;31: 668-674. (Pubitemid 46723643)
21. Leighton JA, Shen B, Baron TH, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006;63:558-565.
22. von Ahsen N, Armstrong VW, Behrens C, et al. Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study. Clin Chem. 2005;51:2282-2288. (Pubitemid 41692571)
23. Higgins LM, McDonald SA, Whittle N, et al. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol. 1999;162:486-493. (Pubitemid 29018958)
24. Solem CA, Loftus EV Jr, Tremaine WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11: 707-712. (Pubitemid 41271173)
25. Lahat A, Chowers Y. The patient with recurrent (sub) obstruction due to Crohn's disease. Best Pract Res. 2007;21:427-444. (Pubitemid 46825478)
26. Maconi G, Carsana L, Fociani P, et al. Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther. 2003;18: 749-756. (Pubitemid 37271841)
27. Theiss AL, Fuller CR, Simmons JG, et al. Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Gastroenterology. 2005;129:204-219. (Pubitemid 41002055)
28. Chiorean MV, Sandrasegaran K, Saxena R, et al. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol. 2007;102:2541-2550. (Pubitemid 47631798)
29. Ebinger M, Leidl R, Thomas S, et al. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol. 2004;19:192-199. (Pubitemid 38253360)
30. Konig HH, Ulshofer A, Gregor M, et al. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14:1205-1215. (Pubitemid 35476879)
31. Schmid RM, Adler G, Liptay S. Activation of NFkappaB in inflammatory bowel disease. Gut. 1998;43:587-588.
32. Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2011;17:984-993.